1-4 of 4
Elizabeth Klein
Close
Sort by
Journal Articles

TNC/Kg and CD34+/Kg Cell Dose Impact on Patient Engraftment after Allogeneic Transplant with Conventional Bone Marrow; Better Predictability of Graft Content Needed

Eric Davis, Elise Feuer, Candice Rapoport, Stephanie Lobaugh, Sean M. Devlin, Anne Archer, Stephanie Chinapen, Jacob Federman, Amanda Kelly, Elizabeth Klein, Melissa Nhaissi, Deborah Wells, Juliet N Barker, Esperanza B. Papadopoulos, Andromachi Scaradavou, Jaap Jan Boelens, Miguel-Angel Perales, Elena Maryamchik, Roni Tamari
Journal: Blood
Blood (2023) 142 (Supplement 1): 113.
https://doi.org/10.1182/blood-2023-190940
Published: 2023
Journal Articles

CD4 + T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation

Clinical Trials & Observations
Coco de Koning, Susan Prockop, Ichelle van Roessel, Nancy Kernan, Elizabeth Klein, Jurgen Langenhorst, Celina Szanto, Mirjam Belderbos, Marc Bierings, Farid Boulad, Dorine Bresters, Maria Cancio, Kevin Curran, Wouter Kollen, Richard O’Reilly, Andromachi Scaradavou, Barbara Spitzer, Birgitta Versluijs, Alwin Huitema, Caroline Lindemans, Stefan Nierkens, Jaap Jan Boelens
Journal: Blood
Blood (2021) 137 (6): 848–855.
https://doi.org/10.1182/blood.2020007905
Published: 2021
Includes: Supplemental data
Journal Articles

Long-Term Follow up of Pediatric Patients with Hodgkin Lymphoma Treated with High Dose Therapy and Autologous Stem Cell Transplantation

Lisa Giulino Roth, MD, Tara O'Donohue MD, Tanya Trippett, MD, Elizabeth Klein, MPH, Nancy A. Kernan, MD, Rachel Kobos, MD, Susan Prockop, MD, Andromachi Scaradavou, MD, Neerav Shukla, MD, Peter G Steinherz, MD, Alison J Moskowitz, MD, Craig H. Moskowitz, MD, Farid Boulad, MD
Journal: Blood
Blood (2015) 126 (23): 2000.
https://doi.org/10.1182/blood.V126.23.2000.2000
Published: 2015
Journal Articles

T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (<21 years) with AML in CR1 or CR2 or MDS Including tMDS/AML

Nancy A. Kernan, MD, Farid Boulad, MD, Susan Prockop, MD, Suzanne Wolden, MD, Andromachi Scaradavou, MD, Rachel Kobos, Rachel Lehrman, Elizabeth Klein, MPH, Kevin J. Curran, MD, Aisha N Hasan, MD, Sharon Bleau, Julianne Ruggiero, PNP, Nicole Zakak, PNP, Anne Casson, PNP, Joanne Torok-Castanza, PNP, Richard J O'Reilly, MD
Journal: Blood
Blood (2015) 126 (23): 5513.
https://doi.org/10.1182/blood.V126.23.5513.5513
Published: 2015